Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
134 participants
OBSERVATIONAL
2009-08-31
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
NCT05733845
Study of the Psychometric Properties of Two Questionnaires for Measuring Disease Flare-up in IBD
NCT06214299
Can CT Enteroclysis Predict the Outcome of Crohn's Disease
NCT00572780
Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel Diseases
NCT03841045
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with Flares of IBD
Active flare of Crohn's or UC
No interventions assigned to this group
Control Group
Patients with quiescent Crohn's disease or UC
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centocor Ortho Biotech Services, L.L.C.
INDUSTRY
Dallas VA Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Linda A Feagins
Staff Gastroenterologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Linda A Feagins, MD
Role: PRINCIPAL_INVESTIGATOR
Dallas VA Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dallas VA Medical Center
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DVAMC-09-010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.